Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Biochemical Society Transactions|July 19, 2013
The dual function of KSR1: a pseudokinase and beyondHua Zhang, Chuay Yeng Koo, Justin Stebbing, et al.Biochimica Et Biophysica Acta|October 8, 2011
FOXM1: From cancer initiation to progression and treatmentChuay-Yeng Koo, Kyle W Muir, Eric W-F LamRecent Patents on Anti-Cancer Drug Discovery|November 11, 2008
Targeting heparan sulfate proteoglycans in breast cancer treatmentChuay-Yeng Koo, Yin-Ping Sen, Boon-Huat Bay, et al.Nature Reviews. Cancer|June 25, 2013
Forkhead box proteins: tuning forks for transcriptional harmonyEric W-F Lam, Jan J Brosens, Ana R Gomes, et al.International Journal of Oncology|November 6, 2007
Comparison of the effects of differentially sulphated bovine kidney- and porcine intestine-derived heparan sulphate on breast carcinoma cellular behaviourChun-Hua Guo, Chuay-Yeng Koo, Boon-Huat Bay, et al.Journal of Cell Science|February 12, 2020
Rnd3 interacts with TAO kinases and contributes to mitotic cell rounding and spindle positioningRitu Garg, Chuay-Yeng Koo, Elvira Infante, et al.Acta Neuropathologica Communications|May 8, 2018
A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathiesCaterina Giacomini, Chuay-Yeng Koo, Natalia Yankova, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 25, 2006
Immunohistochemical expression of heparan sulfate correlates with stromal cell proliferation in breast phyllodes tumorsChuay-Yeng Koo, Boon-Huat Bay, Philip Chi-Wai Lui, et al.Molecular Cancer Research : MCR|July 18, 2012
The p38 MAPK-MK2 axis regulates E2F1 and FOXM1 expression after epirubicin treatmentNatalia de Olano, Chuay-Yeng Koo, Lara J Monteiro, et al.Anatomical Record (Hoboken, N.J. : 2007)|January 15, 2011
Differential expression of metallothionein in gastrointestinal stromal tumors and gastric carcinomasEliza Ting-Li Soo, Cheng-Teng Ng, George Wai-Cheong Yip, et al.Pageof 2